Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rankning i aktier #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Aktiekurs
$0.12164306
Senast synkroniserad: 2024-11-11
Marknadsvärde
$38.53M
Förändring (1 dag)
-4.14%
Förändring (1 år)
0.00%
Land
AU
Handel PharmAust Limited (PAA)

Kategori

Historik för aktiesplit för PharmAust Limited (PAA)
Aktien PharmAust Limited (symbol: PAA) har genomgått totalt 4 aktiesplitar.
Den senaste spliten skedde den Feb 20, 2019.
En PAA-aktie köpt före Nov 15, 2004 motsvarar nu 0.011443846153846 PAA-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2019-02-20 551:500 x1.102 x0.011443846153846
2016-11-10 27:26 x1.0384615384615 x0.010384615384615
2015-10-30 1:20 x0.05 x0.01
2004-11-15 1:5 x0.2 x0.2
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH